Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Agronomed Pharmaceuticals
AddedFeb 16, 2024
UpdatedJun 18, 2026
Agronomed Pharmaceuticals

Agronomed Pharmaceuticals

Series A

Agronomed Pharmaceuticals: Innovating and supplying medical cannabis products through data-driven research.

HQ
Exton, PA, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Agronomed Pharmaceuticals, founded with a mission to innovate in the medical cannabis sector, focuses on cultivating, processing, and supplying cannabis-based health products. The company leverages biochemistry and bio-genetics to develop effective formulations and uses technology to analyze patient outcomes, feeding this data back into their product development cycle. Their market focus is on providing advanced medical cannabis solutions to improve patient health and well-being.

Notable affiliated individuals include experts in biochemistry and bio-genetics, contributing to the company's research-driven approach. Agronomed Pharmaceuticals has achieved significant milestones in the development of data-driven cannabis products, impacting the medical cannabis industry by providing more effective health solutions. Their emphasis on continuous improvement through patient data analysis sets them apart as a leader in the field.

Agronomed Pharmaceuticals - Quick Facts

When was Agronomed Pharmaceuticals founded?

Agronomed Pharmaceuticals was founded in 2017.

Where is Agronomed Pharmaceuticals' headquarters located?

Agronomed Pharmaceuticals' headquarters is located in Exton, PA, US.

When was Agronomed Pharmaceuticals' last funding round?

Agronomed Pharmaceuticals' most recent funding round was for $7.1M (USD) in December 2022.

How much has Agronomed Pharmaceuticals raised to-date?

As of Dec 21, 2022, Agronomed Pharmaceuticals has raised a total of $7.1M (USD).

How many employees does Agronomed Pharmaceuticals have?

Agronomed Pharmaceuticals has 8 employees as of Feb 5, 2024.

Agronomed Pharmaceuticals - Classification

Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Consumers
Main Product
  • Cannabis Products
Tags
  • Data
  • Healthtech
NAICS
  • 459900Other Miscellaneous Retailers
  • 459990All Other Miscellaneous Retailers
  • 459991Tobacco, Electronic Cigarette, and Other Smoking Supplies Retailers
  • 450000Retail Trade
  • 459000Sporting Goods, Hobby, Musical Instrument, Book, and Miscellaneous Retailers
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 1 more industry code
NAICS
  • 620000Health Care and Social Assistance